Paper Details

  1. Home
  2. Paper Details

The T cell-selective IL-2 mutant AIC284 mediates protection in a rat model of Multiple Sclerosis.

Author: BeyersdorfNiklas, HünigThomas, KerkauThomas, KöllnerGabriele, PaulsenDaniela, Rübsamen-SchaeffHelga, WeishauptAndreas, WernerSandra, WolfNelli

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

The study assessed the therapeutic potential of AIC284 in an animal model for Multiple Sclerosis.
Paper Details　
Original Abstract of the Article :
Targeting regulatory T cells (Treg cells) with interleukin-2 (IL-2) constitutes a novel therapeutic approach for autoimmunity. As anti-cancer therapy with IL-2 has revealed substantial toxicities a mutated human IL-2 molecule, termed AIC284 (formerly BAY 50-4798), has been developed to reduce these ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.jneuroim.2015.03.020

データ提供：米国国立医学図書館（NLM）

AIC284: A Potential Oasis in the Desert of Multiple Sclerosis

Multiple sclerosis (MS) is an autoimmune disorder that can feel like a relentless desert storm, characterized by unpredictable attacks and debilitating symptoms. This study investigates the potential of AIC284, a mutated form of interleukin-2 (IL-2), as a therapeutic oasis in this challenging landscape.

The researchers tested the efficacy of AIC284 in a rat model of MS, exploring its ability to modulate immune responses. The results were like finding a hidden spring in the middle of the desert, showing that AIC284 effectively protected the rats from developing MS.

A Glimmer of Hope: AIC284's Potential for Treating MS

This study offers hope for individuals with MS, suggesting that AIC284 could be a valuable tool for managing this complex disorder. This finding is like discovering a hidden oasis in the desert, offering a potential source of relief and a pathway towards a better quality of life.

A New Pathway Through the Desert

The findings of this study highlight the potential of AIC284 as a promising treatment option for MS. This new therapy could offer a way to navigate through the desert of MS, providing a pathway towards a more manageable and fulfilling life.

Dr.Camel's Conclusion

This study provides a glimmer of hope in the desert of MS research. AIC284, a mutated form of IL-2, shows promise in protecting against MS in a rat model. This exciting finding offers a potential oasis in the desert of MS treatment, suggesting that AIC284 could be a valuable tool for managing this complex disorder.

Date :
  1. Date Completed 2015-06-30
  2. Date Revised 2015-04-23
Further Info :

Pubmed ID

25903730

DOI: Digital Object Identifier

10.1016/j.jneuroim.2015.03.020

Related Literature

Article Analysis
・Side Effects of aldesleukin
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.